Form 8-K
8-K — Health In Tech, Inc.
Accession: 0001213900-26-056014
Filed: 2026-05-14
Period: 2026-05-13
CIK: 0002019505
SIC: 6411 (INSURANCE AGENTS BROKERS & SERVICES)
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — ea0290620-8k_health.htm (Primary)
EX-99.1 — TRANSCRIPT (ea029062001ex99-1.htm)
GRAPHIC (ea029062001_ex99-1img1.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0290620-8k_health.htm · Sequence: 1
false
0002019505
0002019505
2026-05-13
2026-05-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934
May 13, 2026
Date of Report (Date of earliest event reported)
Health In Tech, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-42449
87-3545722
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
701 S. Colorado Ave, Suite 1
Stuart, FL
34994
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including
area code: (888) 373-0333
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share
HIT
The Nasdaq Stock Market LLC
(Nasdaq Capital Market)
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
Earnings Call Script
On May 13, 2026, Health In
Tech, Inc., a Nevada corporation (the “Company”), hosted a conference call to discuss its financial and operating results
for the quarter ended March 31, 2026. A transcript of the conference call is furnished as Exhibit 99.1 to this Current Report on Form
8-K. As previously disclosed, a replay of the entire conference call is available for on-demand listening through approximately 90 days
after the date hereof via the Investor Relations page of the Company’s website at https://healthintech.investorroom.com.
The information set forth
in Item 7.01 of this Current Report on Form 8-K and in the attached Exhibit 99.1 are deemed to be “furnished” and shall not
be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that Section. The information set forth in Item 7.01 of this Current Report on
Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities
Act of 1933, as amended, regardless of any general incorporation language in such filing.
Forward-Looking Statements
Certain statements in this
Current Report on Form 8-K or the accompanying exhibits are forward-looking statements for purposes of the safe harbor provisions under
the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health
In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive
position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms
such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,”
“expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,”
“believe,” “continue,” “predict,” “project,” “potential,” “goal,”
or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s
future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s
actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements
because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s
control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and
uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from
those presented in its forward-looking statements are set forth in the “Risk Factors” section in the Company’s Annual
Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission,
as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Any
forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other
risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity.
Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
Exhibit No.
Description
99.1
Transcript.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
1
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 13, 2026
HEALTH IN TECH, INC.
By:
/s/ Tim Johnson
Name:
Tim Johnson
Title:
Chief Executive Officer
2
EX-99.1 — TRANSCRIPT
EX-99.1
Filename: ea029062001ex99-1.htm · Sequence: 2
Exhibit
99.1
Q1
2026 Earnings Conference Call
May
13, 2026
5:00
PM EST (New York)
Presenter
Dial-In ( US/Canada Toll Free): 1-866-250-8117
Presenters
are asked to please connect a minimum of 15 minutes prior to the conference start time. When the speakers are connected, the conference
specialist will do a brief sound check for your line. You will also be asked to review the following items: verify conference title, the
first speaker’s name and pronunciations of other speakers’ names, Q&A restrictions or priority questioners, who will read
the safe harbor language, any questions regarding special services or requests.
Q&A
Link:
The
link below provides access to the Q&A admin portal. There is no need to log in unless you would like to message the host
directly during the call or view who has raised their hand to ask a question.
https://qa6.choruscall.com/contexweb/ViewQA/loginSortQA.htm
View
Q&A Conference Code: 10208973
Operator
Good day, ladies and gentlemen. Thank you for standing by, and welcome
to the Health In Tech first quarter 2026 earnings conference call. Currently, all participants are in listen-only mode. Later, we will
conduct a question-and-answer session, and instructions will follow at that time. As a reminder, we are recording today’s call. If you
have any objections, you may disconnect at this time.
Now I will turn the call over to Lori Babcock, Chief of Staff for the
company, Ms. Babcock, please proceed.
Lori Babcock – Chief of Staff
Thank you, operator, and hello, everyone. Welcome to Health In Tech’s
first quarter 2026 earnings conference call. Joining us today are Mr. Tim Johnson, Chief Executive Officer, Mr. Zain Hasan, Chief Growth
Officer and Ms. Julia Qian, Chief Financial Officer. Full details of our results can be found in our earnings press release and in our
related Form 10-Q, to be filed with the SEC. These documents will be available on our Investor Relations website at healthintech.investorroom.com.
As a reminder, today’s call is being recorded, and a replay will be available on our IR website as well.
Before we continue, please note that today’s discussion includes forward-looking
statements made pursuant to the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements
are based on information available as of today and involve risks, uncertainties, and assumptions that could cause actual results to differ
materially from those expressed or implied, including those discussed in our quarterly report on Form 10-Q for the period ended March
31, 2026, to be filed with the SEC. Please review the forward-looking and cautionary statements section at the end of our earnings release
for various factors that could cause actual results to differ materially from forward-looking statements made during our call today.
Except as expressly required by the federal securities laws, we undertake
no obligation to update and expressly disclaim the obligation to update these forward-looking statements to reflect events or circumstances
after the date of this call or to reflect new information or the occurrence of unanticipated events. We may also refer to certain financial
measures not in accordance with generally accepted accounting principles, such as adjusted EBITDA, for comparison purposes only. Our GAAP
results and reconciliations of GAAP to non-GAAP measures can be found in our earnings press release.
With that, I will now turn the call over to our CEO, Mr. Tim Johnson.
Tim Johnson – CEO
Thank you, Lori, and good afternoon, everyone. We appreciate you joining
us today.
Before discussing the quarter, I want to take a step back and frame
how we are thinking about 2026.
As we discussed during last quarter’s call, we are operating
within a massive, opaque self-funded stop loss insurance market. According to industry estimates, as of 2025, roughly 80% of large businesses
had adopted self-funded healthcare plans, while only about 27% of medium and small businesses had. Self-funded healthcare plans allow
businesses to manage their costs better with a lot of flexibility. However, the complexity has made implementation nearly unrealistic
for many businesses. Our AI-powered solutions remove barriers and make it simple and easy.
The self-funded healthcare market represents nearly a one trillion-dollar
stop loss insurance premium a year, and the total number of insurance brokers exceeds one million according to industry estimates.
In comparison, today just about 900 distribution partners—consisting
primarily of insurance brokers—drive the sale of self-funded plans and stop-loss policies placed through Health In Tech’s
modern technology platform. In other words, our penetration of the broker pool remains well below one-tenth of one percent, which highlights
the significant runway potential ahead, especially given the substantial benefits that our platform aims to deliver: convenience, customization,
cost-effectiveness, clarity, and condensed time to quote.
2025 was a year in which we demonstrated that our model could scale
meaningfully and achieve strong profitability, and our plan is for 2026 to be a year of deliberate investment in sales distribution and
technology development to build our roster of distribution partners, expand our market presence, enhance our technology for new features,
deliver new solutions, and accelerate long-term revenue growth.
In March 2026, we completed a private investment in public equity (PIPE),
which brought us approximately $7 million in gross proceeds that will, in part, support our growth initiatives. To be clear, this capital
raise was not driven by an immediate need for working capital in our view as our business remains strong from a fundamental balance sheet
perspective. Rather, we identified an opportunity to broaden our shareholder base with new institutional investors through a modestly
sized raise that limited dilution and provided incremental fuel for growth.
We intend to prudently deploy this new capital across several targeted
areas, including expanding our sales distribution network, adding new carrier partners to our platform, enhancing our technology architecture
and AI development, and advancing our service offerings and product development.
First, expanding sales distribution.
Our business scales through distribution, with brokers serving as the
primary channel through which employers access self-funded health plans on eDYIBS, our innovative AI-powered marketplace.
In 2026, we are increasing our investment in sales and marketing to
expand our broker network, deepen engagement, and build a more proactive and scalable go-to-market strategy. Historically, much of our
growth has been driven organically by “word of mouth” and through our relatively small in-house sales team. Going forward,
we plan to build our sales team and complement their efforts with more structured outreach, marketing initiatives, and direct engagement
within the broader broker community. Our Chief Growth Officer, Zain Hasan, has more than 15 years of experience in the employee benefits
and insurance industry, he is a five-time founder and former Chief Executive Officer who has successfully built and exited multiple companies.
He brings a proven background in scaling revenue, leading both organic and inorganic growth initiatives, executing strategic acquisitions,
and driving disciplined value creation. He will expand on growth efforts a bit later in the call.
2
We believe these investments are critical to capturing a larger share
of a huge market, in which our current penetration remains very low despite the compelling value-added benefits of our platform.
Second, adding new carrier partners.
On the other side of our platform, we will be focused on increasing
the number and diversity of participating insurance carriers.
I want to spend a moment explaining why adding carriers is important.
Today, our platform generates bindable, execution-ready quotes for employer groups through rapid underwriting that is based on carrier-specific
risk criteria. While our technology significantly improves the speed, consistency, and efficiency of the underwriting process, overall
pricing to the employer reflects a combination of factors across the value chain, such as carrier’s risk assessment, the changes
of underlying employees health condition, claims expense and administrative costs.
Cost variability for the employer at renewal generally boils down to
the carrier’s underwriting criteria and risk assessment, which can fluctuate based on changes in claims experience or shifts in
the carrier’s risk appetite. These fluctuations can lead to less competitive pricing or limited options for the employer at renewal,
even if the broker and employer are otherwise delighted with our platform.
By expanding our carrier network, we can provide brokers with greater
underwriting perspectives for the same employer group, increasing the likelihood of finding a competitive and suitable option within our
platform at renewal.
In practical terms, “more carriers” means more choice for
brokers, better alignment with employer needs, and ultimately a higher probability of successful placement, which we believe will drive
greater platform utilization, enhanced employer “stickiness,”, and stronger revenue growth for Health In Tech.
Third, Health In Tech’s next-generation technology architecture
and AI development. Sri Rajagopalan, our Chief Technology Officer has spent the majority of his career at SAP and IBM, two of the
world’s leading enterprise software companies, where he held senior leadership roles in enterprise architecture and large-scale platform
engineering. His experience spans global, mission-critical systems serving complex enterprise clients across multiple industries. As we
expand our AI-enabled underwriting and benefits administration platform, Sri will strengthen our core technology foundation—enhancing
scalability, data intelligence, cybersecurity, and operational resilience.
Under Sri’s leadership, we announced in March 2026, we engaged
Ciklum, an Amazon Web Service Advanced Tier Service Partner, to expand both the front- and back-end functionality of our technology platform.
Our partnership with Ciklum is off to a strong start. Together, we
are implementing a more integrated technology environment, while streamlining data infrastructure and reporting processes.
We expect to achieve:
● Enhanced platform capabilities and administrative functions that can aid
our expansion into larger employer markets;
● Improved integration of front- and back-end workflows, consolidating quoting,
underwriting, administration, and analytics into a unified platform; and
● Advanced data and operational reporting capabilities to deliver deeper insights
and improved decision-making for brokers, third-party administrators (TPAs), managing general underwriters (MGUs), carriers, and employer
end-clients.
Fourth, advancing services and product development.
To begin, I’m pleased to highlight that, starting in January,
we expanded our service scope with the launch of our enhanced self-funded plan administration offering. This new model delivers pre-configured,
end-to-end self-funded health benefit solutions that bundle plan design, administration, and stop-loss coverage into a single, streamlined
framework.
3
With years of experience, we have developed a comprehensive suite
of more than 100 pre-designed, customizable plans. These plans are curated, bundled, and directly supported by a network of specialized
administrative vendors, enabling us to deliver consistent, high-quality solutions while maintaining flexibility to meet specific employer
needs.
This also reflects an evolution in how we engage with vendors. Historically,
vendors primarily accessed our platform as independent participants, while our role was focused on providing infrastructure and selecting
appropriate vendors. We are now moving toward a more integrated and actively managed model, where we curate, bundle, and manage the vendors
that comprise a self-funded health plan as part of a broader end-to-end solution.
As of March 2026, these pre-configured options address the majority
of employer use cases and can be rapidly deployed, significantly reducing plan design and administrative complexity. For our distribution
partners, this translates into a more efficient sales process.
By taking a more hands-on approach to vendor management, we gain greater
visibility into vendor performance, allowing us to continuously evaluate, refine, and improve the quality of our network. Over time, we
believe this will help us build a best-in-class vendor ecosystem, strengthen platform differentiation, and support higher conversion and
retention across our marketplace.
In addition to expanding our service model, we recently rolled out
a significant update to our eDIYBS platform, designed to make the quoting, underwriting, and communication process faster, more transparent,
and more efficient for brokers.
This update includes a refreshed platform interface, improved workflow
design, enhanced census insights, expanded large-group quoting functionality, improved underwriting status visibility, automated experience
data parsing, AI-driven risk insights, and broker-to-underwriter messaging directly within the platform.
These enhancements are important because they directly address many
of the friction points that have historically slowed down the self-funded quoting and underwriting process. For example, our enhanced
Census Insights capability helps brokers identify data quality and completeness issues before submission, which can reduce back-and-forth
and help minimize underwriting delays. While our platform already supports large-group quoting, the latest enhancements improve the workflow
around larger and more complex cases, including better handling of census data, experience data, and underwriting communication.
We have also introduced broker-to-underwriter messaging, which keeps
communication, files, and updates tied directly to each opportunity rather than scattered across disconnected email threads.
Early feedback from brokers has been very positive, particularly around
the new messaging feature and overall workflow improvements. Brokers have responded well to having communications, files, and updates
tied directly to each opportunity, rather than managed through disconnected email chains. We are also hearing positive feedback on the
RFP ( Request for Proposal) and document upload automation functions, with brokers noting that the process feels smoother, requires less
back-and-forth, and reduces manual steps. While the enhanced Census Insights tool continues to be well received, the strongest reaction
so far has been around the broader efficiency improvements across the platform. Brokers are noticing the impact immediately in their day-to-day
workflow, which we view as an encouraging sign for adoption and continued platform engagement.
Overall, these updates reflect our broader strategy of continuously
enhancing the eDIYBS platform to reduce manual work, improve visibility, and support faster, more accurate quoting and underwriting outcomes.
We believe these capabilities will further strengthen broker adoption, improve partner productivity, and support the scalability of our
marketplace.
4
Among new offerings currently under development, we are making significant
progress with our Three-Year Rate Stabilization Program. We expect to complete market testing of this program late in the second
quarter or early in the third quarter of 2026. This program is designed to address pricing volatility and provide greater cost predictability
for employer groups, which we believe is a key differentiator in the market. Governmental agencies and municipalities, among many others,
stand out as logical candidates for our Three-Year Rate Stabilization Program.
In addition, in the second quarter of 2026 we anticipate commencing
initial beta testing of a new data-driven solution that integrates physiological data and claims data to generate actionable value insights
for partners in our ecosystem and business employer end-clients.
I am incredibly excited about the growth journey in front of us. We
are addressing a vast market opportunity in self-funded health insurance with a comprehensive strategy to expand our ecosystem and democratize
self-funded health insurance for all employers, regardless of size.
Based on our current operating momentum and growing pipeline, we are
reiterating our guidance for full-year 2026 revenue of between $45 million and $50 million, representing approximately 35% to 50% year-over-year
growth.
Before Julia reviews our first quarter financial results, I’ll
turn it over to Zain, who will provide some additional detail on how we are scaling our sales and distribution strategy.
Zain Hasan – Chief Growth Officer
Thank you, Tim.
From a sales perspective, one of our largest opportunities remains
the significant, largely untapped broker and TPA distribution market, where many potential partners have yet to actively engage with our
platform.
We make it easy for brokers and TPAs to join and onboard onto our platform,
which they can use at no cost.
Unlike traditional models that rely on building large in-house sales
teams, we leverage a capital-light, partner-driven distribution strategy. In 2025, and with a relatively small in-house sales team of
6 professionals, we delivered $33 million in revenue. With the additional capital raised through our PIPE financing, we plan to further
invest in and selectively expand our in-house sales team and broaden distribution partners to support continued growth.
Importantly, our in-house sales team is primarily focused on onboarding
and activating distribution partners, rather than directly selling into employer accounts, which allows us to scale efficiently without
significant fixed cost expansion.
This efficiency is driven by our approach: empowering distribution
partners with technology that significantly reduces their cost of doing business. By replacing a manual, email-driven process with a fully
digitized and streamlined workflow, we save brokers a substantial amount of time and improve their ability to serve clients.
In addition, adding more carriers and building an AI driven solutions
to automate length manual processes continue to gain attraction.
5
As we continue to expand our technological capabilities, we intend
to become the go to marketplace for brokers to come to and to offer a one stop shop for the entire renewal process of a self-funded health
plan.
Scaling our expanded capabilities into large employer accounts, would
increase our average contract value of a client; while bringing in additional carriers should improve close rates.
At the same time, we are investing in analytics capabilities that provide
brokers with greater visibility into their quoting pipeline, including win/loss trends, response times, and actionable opportunities.
This represents a meaningful shift toward more data-driven sales management.
While the industry has historically been relationship-driven, we see
a significant opportunity to scale beyond that through more structured engagement. Our go-to-market strategy focuses on increasing direct
broker engagement through conferences, targeted outreach, and brand awareness initiatives—creating a flywheel that drives more platform
usage and increases deals per sales representative.
We are working on building relationships whereby our tech stack becomes
the infrastructure layer for how employee benefit brokers and TPAs serve their self-funded clients, a new strategy for distribution that
we are very optimistic about.
We will be active at key industry conferences where our target buyers
are concentrated using those as catalysts for Executive level engagement and pipeline generation.
Overall, while we are still early in this process, we are encouraged
by the consistency we are seeing and believe we are building a durable, scalable distribution engine that can support long-term growth—without
requiring linear headcount expansion.
I’ll now turn it over to Julia.
Julia Qian – CFO
Thank you, Zain, and good afternoon, everyone. I appreciate you joining
us today.
Before we move on, I’d like to highlight an important
update on how we present our business metrics, which we believe better reflects the underlying growth and visibility of our platform.
We are introducing some new KPIs, or key performance indicators.
I’ll first touch on Contracted Revenue, which represents
contractually committed revenue under active policies, as of the measurement date, that is expected to be recognized in future periods.
Our policies are typically written for terms of 12 months, and under GAAP accounting, the reported revenue is recognized ratably
over the life of the policy.
For example, if a new employer is onboarded on February 1st 2026, under
a 12-month policy, we recognize revenue from that contract monthly from February 2026 through January 2027. In this scenario, while only
two months of revenues are recognized in the Q1 2026 reporting period, the remaining ten-months of contractually committed revenue will
be recognized in the nine remaining months of 2026 and in one month in 2027.
By reporting Contracted Revenue, we are providing investors with greater
transparency and visibility into the future revenue that is already “locked in” – that is, contractually secured but
not yet earned and recognized.
We believe this change aligns our disclosures more closely with how
we manage the business internally and provides investors with a useful metric to evaluate future revenue visibility.
6
As of March 31, 2026, our Contracted Revenue for the remaining three
quarters of 2026 totaled approximately $22.9 million.
In addition to Contracted Revenue, we are now disclosing Platform
Placed Plan Value, or PPPV.
PPPV represents the aggregate contractual value of self-funded health
plans with stop-loss insurance (self-funded stop-loss plans) placed through the Company’s platform, covering the duration of the plans’
contractual terms. The contractual term is typically 12 months from the plan’s effective date.
In the first quarter of 2026, our platform placed $82 million self-funded
stop-loss plans. Platform Placed Plan Value reflects the full value of active policies facilitated through our platform, including
premium, claim funding, and administrative fees.
We believe that PPPV provides a consistent and comparable measure of
the total economic value flowing through our platform.
As our business continues to scale, particularly with expansion into
larger employer groups and more complex plan structures, we expect Platform Placed Plan Value to increase at a faster rate, reflecting
greater depth of engagement and higher-value relationships.
Historically we have disclosed Enrolled Employees as
an operating metric. Enrolled Employees represent individuals or families covered under a company’s self-insured
group health plan.
After careful consideration, we have decided to discontinue this
metric, as we believe Platform Place Plan Value and Contractual Revenue better represent our business.
As Carriers in our platform offer 4 types of coverage (Employee only,
Employee+ Spouse, Employee+ children and Family, and 4 tiers, (bronze, Silver, Gold, Platinum), when previously calculating our now-discontinued
Enrolled Employee metric, a single, individual employee versus a family, inclusive of an employee as well as their spouse and children,
would each be counted as one “enrolled employee,” though the difference of costs and premiums between these two can be 3x-4x.
Furthermore the employee can choose bronze, which offers a lower monthly premium and higher deductible costs, or platinum, which offers
the highest premium and lowest deductible.
These two enrolled employees will have dramatically different premiums.
Moreover, an employer’s enrolled employee count can change during a period due to factors such as resignations, lay-offs, new hires,
family situation changes, births and deaths when we continue to expand our business into larger size of employers and grow our footprint
aggressively. We believe the Enrolled Employee metric couldn’t fully present complexities and dynamics of underlying businesses.
Moving on, as Tim mentioned, we intend for this to be a year of targeted
investment as we scale our distribution network, expand our product capabilities, and position the Company for long-term growth. As a
result, certain financial metrics in the near term reflect this intentional investment phase.
Turning to revenue. For the first quarter of 2026, total revenue
was $8.8 million, representing an increase of approximately 9% year-over-year.
As of March, we estimated $31.7 million in revenue will be reported
in the 2026 fiscal year, with $8.8 million reported in Q1 and $22.9 million to be recognized in the remainder of 2026. This estimated
figure is presented before monthly adjustments, so actual recognized revenue for the remainder of 2026 may differ.
While growth in the quarter was more moderate compared to prior periods,
this reflects the current stage of scaling our business rather than any change in underlying demand or platform capability.
At this stage, revenue growth is more closely tied to the expansion
of our distribution network, the ramp-up of broker activity, and the conversion of pipeline opportunities, in which we are actively investing
in during 2026.
Turning to profitability, adjusted EBITDA for the quarter was
negative $1.3 million, compared to positive $1.2 million in the prior year period, and net loss was $1.6 million compared to net income
of $0.5 million in the prior year period. This reflects our planned increase in investment across key growth initiatives, particularly
in sales and marketing and product development.
7
Turning to operating expenses, total operating expenses for
the quarter were $6.7 million, representing approximately 76% of revenue, compared to $4.9 million, or 61% of
revenue, in the prior year period. Breaking this down further:
Sales and marketing expenses were $2.3 million, representing
approximately 26% of revenue. The investment amount was doubled compared to $1.1 million, or 14% of revenue, in the prior year period.
This increase reflects our deliberate investment in expanding our sales
distribution footprint, including broker expansion, marketing initiatives, and building out a more scalable go-to-market infrastructure.
General and administrative expenses were $3.5 million, representing
approximately 39% of revenue, compared to $3.2 million, or 41% of revenue, in the prior year period. The increase primarily reflects that
we continued to build a stronger team to support a larger and more scalable organization as we grow.
Research and development expenses were $0.9 million, representing
approximately 10% of revenue, compared to $0.5 million, or 7% of revenue, in the prior year period.
This increase reflects continued investment in our technology capabilities
and new product initiatives, including data-driven solutions as well as ongoing enhancements to our underwriting and workflow platform.
In addition to these expenses in R&D investments, we capitalized approximately $0.6 million of software development during the quarter.
Thus, approximately $1.5 million was related to Tech, out of which $0.6 million was related to developing new features and new solutions,
compared to $1.4 million and $0.9 million, respectively, in the prior year period.
Overall, the increase in operating expenses reflects a purposeful shift
in capital allocation toward growth initiatives.
We are investing ahead of revenue to expand distribution, enhance our
product capabilities, and position the Company to capture a larger share of a significant market opportunity.
Importantly, we expect this elevated level of investment to continue
throughout 2026, as we execute on our strategy to scale the business and build a more robust growth engine.
Turning to our cash balance, we ended the quarter with $10.3
million in cash and cash equivalents, reflecting the proceeds from our recent PIPE financing. We continue to maintain a disciplined approach
to capital allocation, with a focus on investing in areas that we believe will drive long-term growth and shareholder value.
In summary, as we continue to scale distribution, increase platform
adoption, and expand our product offerings, we expect to drive higher growth and improve operating leverage over time.
We remain confident in the long-term trajectory of the business and
our ability to execute on our growth strategy.
With that, I’ll now turn it back to the operator for Q&A.
Question-and-Answer Session
Operator
Thank you. Seeing no more questions in the queue, let me turn the call
back to Mr. Johnson for closing remarks.
Tim Johnson– CEO
Thank you, operator and thank you all. I appreciate everyone joining
the call today, if anyone has any follow up questions, please do not hesitate to reach out to us. We appreciate your interest and look
forward to keeping the dialogue open. Thanks everyone.
Operator
Thank you all again. This concludes the call. You may now disconnect.
8
GRAPHIC
GRAPHIC
Filename: ea029062001_ex99-1img1.jpg · Sequence: 3
Binary file (7572 bytes)
Download ea029062001_ex99-1img1.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 8
v3.26.1
Cover
May 13, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 13, 2026
Entity File Number
001-42449
Entity Registrant Name
Health In Tech, Inc.
Entity Central Index Key
0002019505
Entity Tax Identification Number
87-3545722
Entity Incorporation, State or Country Code
NV
Entity Address, Address Line One
701 S. Colorado Ave
Entity Address, Address Line Two
Suite 1
Entity Address, City or Town
Stuart
Entity Address, State or Province
FL
Entity Address, Postal Zip Code
34994
City Area Code
888
Local Phone Number
373-0333
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Class A Common Stock, $0.001 par value per share
Trading Symbol
HIT
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration